Literature DB >> 19336941

Three novel sesquiterpene glycosides of Sarcandra glabra.

Xiao-ru Hu1, Jun-shan Yang, Xu-dong Xu.   

Abstract

Three new sesquiterpene glycosides, 8 beta,9 beta-epoxy-4 alpha-hydroxy-5 alpha H-lindan-7(11)-en-8 alpha,12-olide-15-O-beta-D-glucopyranoside (1, sarcaglaboside F), 4 alpha-hydroxy-5 alpha,8 beta H-lindan-7(11)-en-8 alpha,12-olide-15-O-beta-D-glucopyranoside (2, sarcaglaboside G), 4 alpha-hydroxy-5 alpha,8 beta H-eudesman-7(11)-en-8 alpha,12-olide-15-O-beta-D-glucopyranoside (3, sarcaglaboside H), together with five known compounds, chloranoside A (4), sarcaglaboside C (5), dihydrovomifoliol-O-beta-D-glucopyranoside (6), 9-hydroxy-heterogorgiolide (7) and chloranthalactone B (8), were isolated from Sarcandra glabra THUMB. NAKAI. The structures and relative configurations of three new compounds were determined on the basis of their spectroscopic data and chemical evidence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336941     DOI: 10.1248/cpb.57.418

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

Review 1.  The Traditional Uses, Phytochemistry and Pharmacology of Sarcandra glabra (Thunb.) Nakai, a Chinese Herb With Potential for Development: Review.

Authors:  Yuanlian Zeng; Junyu Liu; Qiang Zhang; Xuhua Qin; Zulun Li; Guojuan Sun; Shenrui Jin
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

2.  Atypical Lindenane-Type Sesquiterpenes from Lindera myrrha.

Authors:  Thuc-Huy Duong; Mehdi A Beniddir; Nguyen T Trung; Cam-Tu D Phan; Van Giau Vo; Van-Kieu Nguyen; Quynh-Loan Le; Hoang-Dung Nguyen; Pierre Le Pogam
Journal:  Molecules       Date:  2020-04-16       Impact factor: 4.411

3.  Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra.

Authors:  Bowen Pan; Sumei Li; Junwei Xiao; Xin Yang; Shouxia Xie; Ying Zhou; Jian Yang; Ying Wei
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.